Track topics on Twitter Track topics that are important to you
MONTERREY, Mexico, July 22, 2015 (GLOBE NEWSWIRE) -- Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (NASDAQ:OMAB) (BMV:OMA), reported its unaudited, consolidated results for the second quarter of 2015 today.
Second quarter 2015 Summary
OMA recorded solid results in the second quarter, as a result of its initiatives to develop passenger traffic, commercial services, and diversification projects. There were double-digit increases in passenger traffic (+16.6%), aeronautical revenues (+17.9%), non-aeronautical revenues (+30.1%), Adjusted EBITDA (+29.1%), and consolidated net income (+29.3%).
The principal results of the second quarter include:
|(Million Passengers and Million Pesos)||2Q14||2Q15||% Var||6M14||6M15||% Var|
|Aeronautical Revenues + Non-Aeronautical Revenues||840||1,015||20.8||1,598||1,929||20.7|
|Income from Operations||362||452||24.8||672||887||31.9|
|Operating Margin (%)||40.7%||41.1%||39.1%||41.8%|
|Adjusted EBITDA Margin (Adjusted EBITDA/Aeronautical Revenues + Non-Aeronautical Revenues, %)||54.4%||58.2%||53.9%||58.4%|
|Consolidated Net Income||214||277||29.3||472||535||13.4|
|Net Income of Controlling Interest||214||276||29.1||471||533||13.1|
|MDP and Strategic Investments||152||195||28.3||290||390||34.5|
|*Based on weighted average shares outstanding|
Revised 2015 Outlook
As a result of the growth in passenger traffic volumes during the first half of the year, and taking into account the maturation of the new routes that operate in the Group's airports, OMA is updating its full year outlook for 2015.
OMA estimates that total passenger traffic growth for 2015 will be between 10% and 12% (previously 6% to 8%). The growth in the sum of aeronautical and non-aeronautical revenues is estimated to be between 13% and 15% (previously 7% to 9%), and non-aeronautical revenues are expected to increase between 18% and 20% (previously 13% to 16%).
The Adjusted EBITDA margin is expected to be between 56% and 58% (previously 53% to 55%).
Master Development Plan investments are expected to be in the range of Ps. 500 to 700 million (unchanged), net of the recognition of land purchases made in prior years (Ps. 131 million in 2015). In addition, strategic investments, principally for diversification projects, are expected to be in the range of Ps. 100 to 200 million (unchanged).
OMA is providing this outlook based on internal estimates. A number of factors could have a significant effect on the estimates of traffic, revenue growth, Adjusted EBITDA, and Capex. These include changes in airline expansion plans, ticket prices and other factors affecting traffic volumes, the evolution of commercial and diversification projects, and economic conditions including oil prices, among others. OMA can provide no assurance that the Company will achieve these results.
OMA's complete earnings report is available at http://ir.oma.aero.
OMA (NASDAQ:OMAB) (BMV:OMA) will hold its 2Q15 earnings conference call on July 23, 2015 at 11 am Eastern time, 10 am Mexico City time.
The conference call is accessible by calling 1-888-417-8533 toll-free from the U.S. or 1-719-325-2362 from outside the U.S. The conference ID is 6521862. A taped replay will be available through July 30, 2015 at 1-877-870-5176 toll free or + 1-858-384-5517, using the same ID.
The conference call will also be available by webcast at http://ir.oma.aero/events.cfm.
This press release may contain forward-looking information and statements. Forward-looking statements are statements that are not historical facts. These statements are only predictions based on our current expectations and projections about future events. Forward-looking statements may be identified by the words "believe," "expect," "anticipate," "target," or similar expressions. While OMA's management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and are generally beyond the control of OMA, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include, but are not limited to, those discussed in our most recent annual report filed on Form 20-F under the caption "Risk Factors." OMA undertakes no obligation to publicly update its forward-looking statements, whether as a result of new information, future events, or otherwise.
Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA, operates 13 international airports in nine states of central and northern Mexico. OMA's airports serve Monterrey, Mexico's fourth largest metropolitan area, the tourist destinations of Acapulco, Mazatlán, and Zihuatanejo, and nine other regional centers and border cities. OMA also operates a hotel and commercial areas inside Terminal 2 of the Mexico City airport. OMA employs over 1,000 persons in order to offer passengers and clients, airport and commercial services in facilities that comply with all applicable international safety, security standards, and ISO 9001:2008. OMA's strategic shareholder members are ICA, Mexico's largest engineering, procurement, and construction company, and Aéroports de Paris Management, subsidiary of Aéroports de Paris, the fourth largest European airports operator. OMA is listed on the Mexican Stock Exchange (OMA) and on the NASDAQ Global Select Market (OMAB). For more information, please visit us at:
CONTACT: OMA Headquarters: +52.81.8625.4300 Chief Financial Officer Jose Luis Guerrero Cortes firstname.lastname@example.org Ext.308 Investor Relations in USA: Daniel Wilson / Zemi Communications email@example.com +1.212.689.9560 Investor Relations in Mexico Vicsaly Torres / firstname.lastname@example.org / +52 81 8625 4309 Emmanuel Camacho / email@example.com / +52 81 8625 4308 Manuel Higinio de Leon / firstname.lastname@example.org / +52 81 8625 4334NEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...